131423-80-8Relevant articles and documents
NOVEL COMPOUNDS FOR DIAGNOSIS
-
Page/Page column 50, (2019/12/28)
The present invention relates to novel compounds that can be employed in the diagnosis, monitoring of disease progression or monitoring of drug activity of a group of disorders and abnormalities associated with alpha-synuclein (α-synuclein, A-synuclein, aSynuclein, a- synuclein, A-syn, α-syn, aSyn, SNCA, Non-amyloid beta component of Alzheimer's disease (AD) amyloid plaques, Non-A4 component of amyloid precursor, NACP) aggregates including, but not limited to, Lewy bodies and/or Lewy neurites, such as Parkinson's disease (PD). The instant compounds are particularly useful in the diagnosis of the preclinical state of such a disorder, monitoring residual disorder, or predicting the responsiveness of a patient who is suffering from such a disorder to the treatment with a certain medicament.
Formation and Pyrolysis of 1-(2'-Thiazolopyridyl)-5-aryltetrazoles
Prasad, V.S.R.,Sambaiah, T.,Reddy, K. Kondal
, p. 1983 - 1988 (2007/10/02)
1-(2'-Thiazolopyridyl)-5-aryltetrazoles (4) have been obtained by the reaction of 2-aroylaminothiazolopyridines (2) with phosphorus pentachloride and azidolysis of the resulting imidoyl chlorides.The products of pyrolysis of 1-(2'-thiazolopyridyl)-5-aryltetrazoles in decalin have been characterised as 2-aryl-1,2,4-triazolothiazolopyridines (6).